


Searching News Database: Y's Therapeutics
HSMN NewsFeed - 14 May 2024
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
HSMN NewsFeed - 25 Oct 2007
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
Additional items found! 3
Members Archive contains
3 additional stories matching:
Y's Therapeutics
(Password required)
Y's Therapeutics
(Password required)
